Tevogen Bio Holdings Inc. (TVGN): Qarzning balans kapitallashuviga nisbati
Tevogen Bio Holdings (TVGN) saraton va viruslarga qarshi kurashish uchun immun himoyasini kuchaytirish usullarini ishlab chiqish orqali tibbiy xavflarni minimallashtiradi. T-hujayra mahsulotlarining muvaffaqiyatli sinov bosqichlari va potentsial litsenziyalash kelishuvlari biznes o'sishini ta'minlamoqda. Rad etilmaydigan terapiyalarni ishlab chiqish uchun mo'ljallangan noyob dasturiy ta'minot va kuchli patent himoyasi texnologik ustunlikni beradi. Joriy ko'rsatkich 0.00 ni tashkil etadi va aktivning GURU.Markets platformasidagi bozor dinamikasi quyida keltirilgan.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_TVGN_-_Tevogen-Bio-Holdings_-_Debt-to-Net-Assets-Ratio "TVGN: Tevogen Bio Qarzning balans kapitallashuviga nisbati 21.02.2024 - 29.10.2026 | 👁️GURU.Markets👁️")
TVGN (Tevogen Bio Holdings Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning kapitalga nisbati Tevogen Bio Holdings|TVGN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Tevogen Bio Holdings, Inc.|TVGN - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Tevogen Bio Inc.|TVGN - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzlari Tevogen Bio
Kompaniyaning jamlanma tahliliyoti:TVGN (Tevogen Bio Holdings)
Tevogen Bio Holdings (TVGN) aksiyalarining fundamental tayanch darajasini aniqlash uchun ExCITE platformasi patentlarining qiymatini FDA ning qat'iy nazorati ostidagi qarz yuklamasi bilan bog'liqligini tekshirish zarurdir. GURU.Markets platformasida kompaniyaning qarzning kitob kapitalizatsiyasiga nisbati koeffitsientini tahlil qilish orqali investor umumiy majburiyatlarning kitob qiymatiga nisbatini aniqlashi mumkin, bu esa defolt xavfini va tartibga soluvchi o'zgarishlar qarshisida aktivning moliyaviy barqarorligini baholash imkonini beradi.
Raqobatchilar tahlili
Biogen Inc. - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar neurocrine.com NBIX|RGC - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AXSM (Axsome)|ACADIA Pharmaceuticals Inc (ACAD) - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Xenon Corp (XENE)|Qarzning balans qiymatiga nisbati VKTX|SUPN (supernus.com) - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar CPRX|DNLI - Balans qiymatiga qarzlar|Harmony Pharma - Qarzning balans qiymatiga nisbati|Biohaven Corp - Qarzning balans kapitallashuviga nisbati|AMLX - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar trevitherapeutics.com|PRAX: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Anavex AVXL|CBLL (CeriBell Corp) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar prothena.com PRTA|Qarzning balans kapitallashuviga nisbati Alector, Inc. (ALEC)|annexonbio.com - Qarzning balans qiymatiga nisbati|Omeros - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati NGNE|AC Immune Corp - Balans kapitallashuviga qarzlar|VYGR: Qarzning balans kapitallashuviga nisbati|NMRA: Balans kapitallashuviga qarzlar|SCLX - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Alpha Cognition Inc|Balans qiymatiga qarzlar Cognition Therapeutics Inc. CGTX|Qarzning balans qiymatiga nisbati IKT (Inhibikase)|SAVA (Cassava Pharma) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar ASRT (Assertio)|Qarzning sof aktivlarga nisbati COYA|VTGN - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Ovid Therapeutics Inc.|Acumen Pharma (ABOS) - Qarzning balans kapitallashuviga nisbati|CRVO (CervoMed Corporation) - Qarzning balans kapitallashuviga nisbati|ATHE (Alterity Therapeutics Ltd.) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati CLNN (Clene Nanomedicine)|Balans kapitallashuviga qarzlar PEPG|Sof aktivlarga qarzlar Jupiter Neurosciences, Inc.|Qarzning balans kapitallashuviga nisbati Relmada RLMD|ANVS: Qarzning balans qiymatiga nisbati|Grace Tx - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati fireflyneuro.com (AIFF)|anewmeds.com (KLTO) - Qarzning balans kapitallashuviga nisbati|NRSN - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati RVPH|MTVA (MetaVia, Inc.) - Qarzning balans kapitaliga nisbati|Qarzning balans qiymatiga nisbati NRXS (NeurAxis, Inc.)|Qarzning balans kapitallashuviga nisbati HSDT (heliusmedical.com)|Balans kapitallashuviga qarzlar PASG (Passage Bio)|Qarzning sof aktivlarga nisbati Neuphoria Therapeutics, Inc.|NERV - Qarzning balans kapitallashuviga nisbati|ATHA (Athira Pharma Corp) - Qarzning balans qiymatiga nisbati|Addex Therapeutics (ADXN) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati ALZN|CYCN (Cyclerion Therapeutics Inc.) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Protagenic PTIX|Qarzning balans qiymatiga nisbati KTTA (Pasithea Therapeutics)|Balans kapitallashuviga qarzlar cortigent.com (CRGT)|Qarzning balans kapitallashuviga nisbati Avenue Therapeutics ATXI|Qarzning sof aktivlarga nisbati BCLI|CARA - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Chromocell Therapeutics Corp|ELYM (eliemtx.com) - Qarzning balans qiymatiga nisbati|ITCI: Qarzning balans kapitaliga nisbati|LBPH (Longboard Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar marinuspharma.com MRNS|Qarzning balans qiymatiga nisbati NKGN (NKGen Biotech)|Qarzning balans kapitallashuviga nisbati NRBO (NeuroBo Pharmaceuticals Inc)|Qarzning balans kapitallashuviga nisbati Sage Therapeutics, Inc SAGE|Synaptogenix, Inc (SNPX) - Balans qiymatiga qarzlar|Trevena, Inc. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati Vigil Neuroscience (VIGL)|WENA: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Cerevel Therapeutics Inc (CERE)